US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist
  • 795.350
  • +7.160+0.91%
Close Nov 29 13:00 ET
  • 795.300
  • -0.050-0.01%
Post 17:01 ET
755.04BMarket Cap85.98P/E (TTM)

Eli Lilly and Co Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
20.43%11.44B
35.98%11.3B
25.98%8.77B
19.56%34.12B
28.10%9.35B
36.84%9.5B
28.11%8.31B
-10.88%6.96B
0.79%28.54B
-8.73%7.3B
Operating revenue
20.43%11.44B
35.98%11.3B
25.98%8.77B
19.56%34.12B
28.10%9.35B
36.84%9.5B
28.11%8.31B
-10.88%6.96B
0.79%28.54B
-8.73%7.3B
Cost of revenue
16.70%2.17B
20.07%2.17B
2.88%1.67B
6.82%7.08B
15.50%1.79B
17.79%1.86B
26.35%1.81B
-21.50%1.63B
-9.34%6.63B
-24.49%1.55B
Gross profit
21.34%9.27B
40.40%9.13B
33.02%7.09B
23.41%27.04B
31.49%7.57B
42.44%7.64B
28.61%6.5B
-7.05%5.33B
4.31%21.91B
-3.29%5.75B
Operating expense
14.74%4.83B
13.15%4.71B
20.46%4.36B
22.60%16.25B
23.24%4.03B
23.29%4.21B
25.77%4.17B
17.69%3.62B
1.42%13.26B
-4.43%3.27B
Selling and administrative expenses
16.40%2.1B
10.67%2B
12.41%1.84B
14.40%6.94B
15.15%1.46B
11.75%1.8B
18.23%1.81B
11.53%1.63B
-1.21%6.07B
-16.39%1.27B
-General and administrative expense
16.40%2.1B
10.67%2B
12.41%1.84B
14.40%6.94B
15.15%1.46B
11.75%1.8B
18.23%1.81B
11.53%1.63B
-1.21%6.07B
-16.39%1.27B
Research and development costs
13.49%2.73B
15.05%2.71B
27.09%2.52B
29.52%9.31B
28.40%2.56B
33.62%2.41B
32.25%2.36B
23.29%1.99B
3.75%7.19B
5.14%2B
Operating profit
29.45%4.43B
88.95%4.42B
59.53%2.74B
24.66%10.79B
42.31%3.54B
76.08%3.43B
34.02%2.34B
-35.61%1.71B
9.08%8.65B
-1.76%2.49B
Net non-operating interest income expense
-91.41%-144.9M
-96.90%-146.3M
-95.04%-133.8M
-16.18%-312.3M
-60.17%-93.7M
-23.29%-75.7M
-4.65%-74.3M
11.94%-68.6M
14.50%-268.8M
20.95%-58.5M
Non-operating interest income
-2.25%47.8M
-18.91%37.3M
33.92%45.8M
176.43%173.6M
74.51%44.5M
143.28%48.9M
350.98%46M
388.57%34.2M
147.24%62.8M
244.59%25.5M
Non-operating interest expense
54.65%192.7M
52.62%183.6M
74.71%179.6M
46.53%485.9M
64.52%138.2M
52.88%124.6M
48.15%120.3M
21.08%102.8M
-2.41%331.6M
3.19%84M
Other net income (expense)
7.58%-2.7B
-330.94%-755M
43.61%-65.7M
-148.43%-3.92B
-181.87%-937.5M
-817.61%-2.92B
69.94%-175.2M
78.09%-116.5M
-7.86%-1.58B
46.19%-332.6M
Gain on sale of security
278.70%112.4M
-143.30%-157.9M
216.79%16M
95.08%-20.2M
-52.78%121.3M
48.99%-62.9M
45.42%-64.9M
96.78%-13.7M
-332.17%-410.7M
375.64%256.9M
Special income (charges)
2.26%-2.91B
-506.90%-589.3M
-5.24%-110.5M
-235.40%-3.87B
-148.13%-690.3M
-1,006.40%-2.98B
77.95%-97.1M
36.59%-105M
31.83%-1.15B
48.69%-278.2M
-Less：Restructuring and merger&acquisition
----
----
----
97.83%45.5M
----
----
----
----
76.92%23M
----
-Less:Impairment of capital assets
--81.6M
--435M
----
----
----
--0
--0
----
----
----
-Less:Other special charges
-5.00%2.83B
58.91%154.3M
5.24%110.5M
318.25%3.8B
159.31%622.6M
4,667.79%2.98B
-77.95%97.1M
-36.59%105M
-33.94%908.5M
-45.15%240.1M
-Write off
----
----
----
-89.98%22.2M
----
----
----
----
-26.89%221.6M
----
Other non- operating income (expenses)
-18.11%94.5M
40.91%-7.8M
1,209.09%28.8M
-128.67%-32.7M
-18.37%-368.5M
56.58%115.4M
44.07%-13.2M
-96.29%2.2M
-127.82%-14.3M
-1,899.42%-311.3M
Income before tax
271.82%1.59B
68.38%3.52B
65.79%2.54B
-3.70%6.55B
19.67%2.51B
-72.71%427.2M
91.48%2.09B
-25.51%1.53B
10.57%6.81B
13.94%2.1B
Income tax
27.55%618.1M
68.93%550.2M
58.66%293.2M
134.01%1.31B
101.07%319.1M
325.83%484.6M
135.33%325.7M
22.63%184.8M
-2.13%561.6M
39.46%158.7M
Net income
1,790.42%970.3M
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
Net income continuous Operations
1,790.42%970.3M
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
Minority interest income
Net income attributable to the parent company
1,790.42%970.3M
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1,790.42%970.3M
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
Basic earnings per share
1,900.00%1.08
67.86%3.29
67.11%2.49
-16.02%5.82
19.38%2.4346
-103.73%-0.06
84.91%1.96
-29.38%1.49
12.68%6.93
12.67%2.0393
Diluted earnings per share
1,883.33%1.07
68.21%3.28
66.44%2.48
-15.94%5.8
18.67%2.42
-103.73%-0.06
85.71%1.95
-29.05%1.49
12.75%6.9
12.67%2.0393
Dividend per share
15.04%1.3
15.04%1.3
15.04%1.3
15.31%4.52
15.31%1.13
15.31%1.13
15.31%1.13
15.31%1.13
15.29%3.92
15.29%0.98
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 20.43%11.44B35.98%11.3B25.98%8.77B19.56%34.12B28.10%9.35B36.84%9.5B28.11%8.31B-10.88%6.96B0.79%28.54B-8.73%7.3B
Operating revenue 20.43%11.44B35.98%11.3B25.98%8.77B19.56%34.12B28.10%9.35B36.84%9.5B28.11%8.31B-10.88%6.96B0.79%28.54B-8.73%7.3B
Cost of revenue 16.70%2.17B20.07%2.17B2.88%1.67B6.82%7.08B15.50%1.79B17.79%1.86B26.35%1.81B-21.50%1.63B-9.34%6.63B-24.49%1.55B
Gross profit 21.34%9.27B40.40%9.13B33.02%7.09B23.41%27.04B31.49%7.57B42.44%7.64B28.61%6.5B-7.05%5.33B4.31%21.91B-3.29%5.75B
Operating expense 14.74%4.83B13.15%4.71B20.46%4.36B22.60%16.25B23.24%4.03B23.29%4.21B25.77%4.17B17.69%3.62B1.42%13.26B-4.43%3.27B
Selling and administrative expenses 16.40%2.1B10.67%2B12.41%1.84B14.40%6.94B15.15%1.46B11.75%1.8B18.23%1.81B11.53%1.63B-1.21%6.07B-16.39%1.27B
-General and administrative expense 16.40%2.1B10.67%2B12.41%1.84B14.40%6.94B15.15%1.46B11.75%1.8B18.23%1.81B11.53%1.63B-1.21%6.07B-16.39%1.27B
Research and development costs 13.49%2.73B15.05%2.71B27.09%2.52B29.52%9.31B28.40%2.56B33.62%2.41B32.25%2.36B23.29%1.99B3.75%7.19B5.14%2B
Operating profit 29.45%4.43B88.95%4.42B59.53%2.74B24.66%10.79B42.31%3.54B76.08%3.43B34.02%2.34B-35.61%1.71B9.08%8.65B-1.76%2.49B
Net non-operating interest income expense -91.41%-144.9M-96.90%-146.3M-95.04%-133.8M-16.18%-312.3M-60.17%-93.7M-23.29%-75.7M-4.65%-74.3M11.94%-68.6M14.50%-268.8M20.95%-58.5M
Non-operating interest income -2.25%47.8M-18.91%37.3M33.92%45.8M176.43%173.6M74.51%44.5M143.28%48.9M350.98%46M388.57%34.2M147.24%62.8M244.59%25.5M
Non-operating interest expense 54.65%192.7M52.62%183.6M74.71%179.6M46.53%485.9M64.52%138.2M52.88%124.6M48.15%120.3M21.08%102.8M-2.41%331.6M3.19%84M
Other net income (expense) 7.58%-2.7B-330.94%-755M43.61%-65.7M-148.43%-3.92B-181.87%-937.5M-817.61%-2.92B69.94%-175.2M78.09%-116.5M-7.86%-1.58B46.19%-332.6M
Gain on sale of security 278.70%112.4M-143.30%-157.9M216.79%16M95.08%-20.2M-52.78%121.3M48.99%-62.9M45.42%-64.9M96.78%-13.7M-332.17%-410.7M375.64%256.9M
Special income (charges) 2.26%-2.91B-506.90%-589.3M-5.24%-110.5M-235.40%-3.87B-148.13%-690.3M-1,006.40%-2.98B77.95%-97.1M36.59%-105M31.83%-1.15B48.69%-278.2M
-Less：Restructuring and merger&acquisition ------------97.83%45.5M----------------76.92%23M----
-Less:Impairment of capital assets --81.6M--435M--------------0--0------------
-Less:Other special charges -5.00%2.83B58.91%154.3M5.24%110.5M318.25%3.8B159.31%622.6M4,667.79%2.98B-77.95%97.1M-36.59%105M-33.94%908.5M-45.15%240.1M
-Write off -------------89.98%22.2M-----------------26.89%221.6M----
Other non- operating income (expenses) -18.11%94.5M40.91%-7.8M1,209.09%28.8M-128.67%-32.7M-18.37%-368.5M56.58%115.4M44.07%-13.2M-96.29%2.2M-127.82%-14.3M-1,899.42%-311.3M
Income before tax 271.82%1.59B68.38%3.52B65.79%2.54B-3.70%6.55B19.67%2.51B-72.71%427.2M91.48%2.09B-25.51%1.53B10.57%6.81B13.94%2.1B
Income tax 27.55%618.1M68.93%550.2M58.66%293.2M134.01%1.31B101.07%319.1M325.83%484.6M135.33%325.7M22.63%184.8M-2.13%561.6M39.46%158.7M
Net income 1,790.42%970.3M68.27%2.97B66.77%2.24B-16.08%5.24B13.01%2.19B-103.95%-57.4M85.11%1.76B-29.32%1.34B11.88%6.24B12.26%1.94B
Net income continuous Operations 1,790.42%970.3M68.27%2.97B66.77%2.24B-16.08%5.24B13.01%2.19B-103.95%-57.4M85.11%1.76B-29.32%1.34B11.88%6.24B12.26%1.94B
Minority interest income
Net income attributable to the parent company 1,790.42%970.3M68.27%2.97B66.77%2.24B-16.08%5.24B13.01%2.19B-103.95%-57.4M85.11%1.76B-29.32%1.34B11.88%6.24B12.26%1.94B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1,790.42%970.3M68.27%2.97B66.77%2.24B-16.08%5.24B13.01%2.19B-103.95%-57.4M85.11%1.76B-29.32%1.34B11.88%6.24B12.26%1.94B
Basic earnings per share 1,900.00%1.0867.86%3.2967.11%2.49-16.02%5.8219.38%2.4346-103.73%-0.0684.91%1.96-29.38%1.4912.68%6.9312.67%2.0393
Diluted earnings per share 1,883.33%1.0768.21%3.2866.44%2.48-15.94%5.818.67%2.42-103.73%-0.0685.71%1.95-29.05%1.4912.75%6.912.67%2.0393
Dividend per share 15.04%1.315.04%1.315.04%1.315.31%4.5215.31%1.1315.31%1.1315.31%1.1315.31%1.1315.29%3.9215.29%0.98
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday+0.87%
Donald Trump
Donald Trump
Intraday+0.69%